Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT03718936Recruiting

ADNP Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing ADNP-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures.

Showing all 1 trials

Research Network

Active Sponsors

  • Icahn School of Medicine at Mount Sinai1
  • Research Foundation for Mental Hygiene, Inc.1
  • The Seaver Foundation1
  • Autism Science Foundation1

Top Investigators

Related Conditions

  • Adnp1
  • Autism Spectrum Disorder1

Activity Timeline